ACCORD clinical trial publishes results
Published: Friday, June 6, 2008 - 16:35
in Health & Medicine
Intensively targeting blood sugar to near-normal levels in adults with type 2 diabetes at especially high risk for heart attack and stroke does not significantly reduce the risk of major cardiovascular events, such as fatal or nonfatal heart attacks or stroke, but increases risk of death, compared to standard treatment. Researchers from the ACCORD (Action to Control Cardiovascular Risk in Diabetes) clinical trial compared a medical strategy aimed at near-normal blood sugar levels
Source: NIH/National Heart, Lung and Blood Institute
Articles on the same topic
- Having heart surgery? Watch your blood sugar, especially if you're overweight or olderSat, 7 Jun 2008, 17:28:24 UTC
- Study finds link between amphetamine abuse and heart attacks in young adultsWed, 4 Jun 2008, 14:28:52 UTC
Other sources
- Tight Rein on Blood Sugar Has No Heart Benefitsfrom NY Times HealthTue, 10 Jun 2008, 23:21:17 UTC
- Having heart surgery? Watch your blood sugar, especially if you're overweight or olderfrom PhysorgSun, 8 Jun 2008, 18:14:11 UTC
- Having Heart Surgery? Watch Your Blood Sugar, Especially If You're Overweight Or Olderfrom Science DailySat, 7 Jun 2008, 19:21:06 UTC
- Intense diabetes therapy didn't cut heart problemsfrom AP HealthFri, 6 Jun 2008, 23:14:26 UTC
- Targeting Blood Sugar To Near-normal Levels Increases Risk Of Death In Persons With Diabetes At High Risk, ACCORD Trial Showsfrom Science DailyFri, 6 Jun 2008, 22:21:17 UTC
- Aggressive approach to diabetes proves harmfulfrom News @ NatureFri, 6 Jun 2008, 22:21:10 UTC
- Study finds link between amphetamine abuse and heart attacks in young adultsfrom PhysorgWed, 4 Jun 2008, 15:14:43 UTC
- Amphetamine Abuse Linked To Heart Attacks In Young Adultsfrom Science DailyWed, 4 Jun 2008, 14:28:30 UTC